A Safety, Tolerability, and Efficacy Study of Type 1 Diabetes
See If You Qualify
Status
Recruiting
ClinicalTrials.gov Identifier
NCT01234567
ABCPharma Study ID
555 55555
Eligibility Criteria
Sex
Age
18 Years - 65 Years
Phase
Phase
Phase
-
Other protocol defined Inclusion/Exclusion criteria may apply.
-
Other protocol defined Inclusion/Exclusion criteria may apply.
Trial Details
This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes mellitus (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia.
Condition
Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia
Study Duration
March 2021 - January 2028
Study Type
Interventional
Intervention/Treatment
Biological : VX-880
Estimated Enrollment
17
Share this trial
ABCPharma Registry
Join and get connected to clinical trials that may be right for you
When you volunteer to participate in clinical research, you help advance medical care for yourself and
your
community. We make it easy to get involved in the research that matters to you.
Visit Registry
Search for the closest clinical trial from your location
| Location | Status |
|---|---|
|
City of Hope
0 mi
Duarte California 91010 United States
|
|
|
UHealth Diabetes Research Institute
977 mi
Miami Florida 33136 United States
|
|
|
Northwestern Organ Transplant Center
977 mi
Chicago Illinois 60611 United States
|
|
|
University of Chicago
3 mi
Chicago Illinois 60637 United States
|
|
|
Massachusetts General Hospital
1 mi
Boston Massachusetts 02114 United States
|
